Apollo Hospitals Enterprise Limited (APOLLOHOSP) AI Stock Analysis

• Market Cap: ₹1.08T
• Dividend Yield: 0.27%
• Average Volume (3M): 4.82K
• Price to Earnings (P/E): 50.4
• Beta (1Y): 0.91
• Revenue Growth: 13.66%
• EPS Growth: 41.32%
• Country: IN
• Employees: 83,147
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 35.90
• Shares Outstanding: 143,784,650
• 10 Day Avg. Volume: 6,428
• 30 Day Avg. Volume: 4,819
• PEG Ratio: 1.08
• Price to Book (P/B): 11.61
• Price to Sales (P/S): 4.38
• P/FCF Ratio: 441.29
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹8,820.00
• Price Target Upside: 24.55% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): 165.98
• Revenue Forecast (FY): ₹302.15B

• Rating: 66 Neutral
• Price Target: ₹7,397.00 ▲(4.46% Upside)
• Action: Reiterated Date: 11/01/25
• Date: Action: Reiterated 11/01/25

Apollo Hospitals' strong financial performance is the primary driver of its stock score, supported by robust revenue growth and efficient cash flow management. However, technical indicators suggest potential bearish trends, and the high P/E ratio indicates possible overvaluation, which tempers the overall score.

Positive Factors

Revenue Growth

Sustained revenue growth (~13.7% reported) signals durable demand for Apollo’s services across hospitals, diagnostics and pharmacies. This supports capacity utilization, reinvestment in high-return services and long-term earnings expansion as the company scales its integrated care model.

Negative Factors

Rising Capital Expenditure Pressure

Higher capex reduces free cash flow and can constrain discretionary investments or dividend flexibility if sustained. Ongoing heavy investments require clear return paths; otherwise they may compress margins or force additional financing, weakening long-term cash returns to shareholders.

Apollo Hospitals Enterprise Limited Business Overview & Revenue Model

Company Description

Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India and internationally. The company's healthcare facilities comprise primary, secondary, and tertiary care facilities. Its tertiary care hospit...

Read more

Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India and internationally. The company's healthcare facilities comprise primary, secondary, and tertiary care facilities. Its tertiary care hospit...

How the Company Makes Money

Apollo Hospitals generates revenue primarily through its hospital operations, which include inpatient and outpatient services. The company charges fees for various medical services, surgeries, and treatments provided in its hospitals. Additionally...

Read more

Apollo Hospitals generates revenue primarily through its hospital operations, which include inpatient and outpatient services. The company charges fees for various medical services, surgeries, and treatments provided in its hospitals. Additionally...

Apollo Hospitals Enterprise Limited Financial Statement Overview

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	232.65B	217.94B	190.59B	166.13B	146.63B	105.60B
Gross Profit	76.71B	73.50B	63.98B	56.68B	51.31B	31.40B
EBITDA	31.67B	27.98B	22.11B	19.11B	20.45B	9.75B
Net Income	16.72B	14.46B	8.99B	8.19B	10.56B	1.50B
Balance Sheet
Total Assets	219.50B	206.57B	167.53B	144.28B	131.92B	114.17B
Cash, Cash Equivalents and Short-Term Investments	31.44B	27.93B	11.89B	7.26B	10.48B	14.23B
Total Debt	79.87B	78.64B	53.33B	43.32B	40.68B	41.60B
Total Liabilities	123.97B	120.05B	94.33B	78.96B	73.15B	66.14B
Stockholders Equity	90.93B	82.12B	69.35B	61.97B	56.23B	46.02B
Cash Flow
Free Cash Flow	6.19B	2.16B	7.83B	2.49B	9.71B	9.78B
Operating Cash Flow	13.25B	19.29B	19.20B	13.77B	16.28B	12.73B
Investing Cash Flow	-10.70B	-34.77B	-15.37B	-8.71B	-8.47B	-8.72B
Financing Cash Flow	-3.48B	16.21B	-3.11B	-6.33B	-7.93B	-3.40B

Apollo Hospitals Enterprise Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 7081.40
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:APOLLOHOSP, the sentiment is Positive. The current price of 7081.4 is below the 20-day moving average (MA) of 7450.43, below the 50-day MA of 7421.72, and below the 200-day MA of 7431.68, indicating a bullish trend. The MACD of -32.70 indicates Positive momentum. The RSI at 51.43 is Neutral, neither overbought nor oversold. The STOCH value of 56.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:APOLLOHOSP.

Apollo Hospitals Enterprise Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NH	71 Outperform	₹358.56B	75.82	―	0.24%	14.72%	8.37%
APOLLOHOSP	66 Neutral	₹1.08T	50.39	―	0.27%	13.66%	41.32%
MAXHEALTH	66 Neutral	₹928.43B	84.46	―	0.14%	32.17%	28.12%
MEDANTA	65 Neutral	₹286.32B	83.79	―	0.04%	15.78%	15.01%
FORTIS	61 Neutral	₹639.79B	86.12	―	0.11%	15.33%	54.62%
METROPOLIS	61 Neutral	₹97.09B	60.35	―	0.21%	15.41%	5.93%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Apollo Hospitals Enterprise Limited Corporate Events